News | February 21, 2024
Q32 Bio Announces Publication of Preclinical Data in Molecular Therapy Demonstrating the Therapeutic Potential of Tissue-Targeted Complement Inhibitor ADX-097 for Complement-Mediated Diseases
Read More
Press Release | February 15, 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Read More
Press Release | February 8, 2024
Metagenomi Announces Pricing of Initial Public Offering
Read More
Press Release | February 4, 2024
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Read More
